赛格恩和Springer Nature为传染病研究发起"自然奖MDx影响性资助",每项项目提供60万美元的资助. Seegene and Springer Nature launch 'Nature Awards MDx Impact Grants' for infectious disease research with $600K funding per project.

Seegene Inc. 和Springer自然公司推出了“自然奖MDx影响赠款”,以便利用Seegene的多功能PCR技术推进诊断性分析。 Seegene Inc. and Springer Nature have introduced the 'Nature Awards MDx Impact Grants' to advance diagnostic assays using Seegene's multiplex PCR technology. 世界各地的研究人员可以提议针对人类传染病的项目,每个项目最多可得到60万美元的资金。 Researchers worldwide can propose projects targeting human infectious diseases, with funding up to $600,000 available per project. 支助包括分析、仪器和软件。 Support includes assays, instruments, and software. 提案应于2024年12月2日前提交,获奖者于2025年8月宣布。 Proposals are due by December 2, 2024, with winners announced in August 2025.